Precision LBx Summit

Precision LBx Summit is bringing together leaders from biopharma, academia and Dx developers to build the annual platform that dictates the direction and rhetoric of the evolving liquid biopsy story.

30 January 1 February 2017

Currently in read only mode, sorry about that, please try again in a few hours.

7 speakers

  • Stefan Scherer Vice President, Global Head Correlative Science, Novartis
  • Pallavi Sachdev Associate Director, Oncology Biomarker Research, Clinical Development, Eisai
  • Kenneth Thress Director, Oncology Translational Science, Astrazeneca
  • Thomas Schlange Senior Biomarker Scientist, Bayer and EFPIA Coordinator, IMI Cancer-ID
  • Jean-Francois Martini Senior Director, Translational Oncology, EDTO group, Pfizer
  • George Vasmatzis Co-Director Biomarker Discovery Program, Center for Individualized Medicine, Mayo Clinic
  • Samir Hanash Director, Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer, The University of Texas MD Anderson Cancer Center

1 session

Conferences Day 1 from 8am to 6pm Monday 30th January 2017

Conferences Day 2 from 8am to 6pm Tuesday 31st January 2017

Conferences Day 3 from 8am to 6pm Wednesday 1st February 2017

1 person tracking this event

  • evvnt Platform

Tell your friends!

Share this event with your friends on Twitter


See something wrong?

Report an issue with this event